ISD Control

Control for CDS Ligand ISD

ISD Control is a negative control for the CDS agonist ISD. It is a non-immunostimulatory single-stranded oligonucleotide with the same sequence as ISD, its double-stranded counterpart. The CDS agonist ISD (interferon stimulatory DNA) is a 45-bp non-CpG oligomer from the Listeria monocytogenes genome. L. monocytogenes, the bacterium responsible for listeriosis, is a Gram-positive, facultative intracellular pathogen. This bacterium proliferates rapidly in the host cell cytosol while largely evading the induction of host cell death.

ISD Control/LyoVec™ is a formulation of ISD Control complexed with the cationic lipid transfection reagent LyoVec™ to facilitate its cellular uptake.

Mode of action:

Intracellular DNA from pathogens is recognized by multiple cytosolic DNA sensors (CDSs), which display contextual preferences for the recognition of DNA [1]. When transfected into various cell types, including plasmacytoid and conventional DCs, macrophages, and murine embryonic fibroblasts, ISD strongly enhances the expression of IFN-β [1]. This ISD-induced response is mediated by the STING-TBK1-IRF3 signaling axis [1-2].

ISD Control is a single-stranded oligonucleotide which, unlike its double-stranded counterpart, ISD, is not an IFN-inducer. 

Key features of ISD Control:

• Negative control for ISD
• Available naked or complexed with the cationic lipid LyoVec™
• Each lot is functionally validated

Read our review on cytosolic DNA sensors

References:

1. Stetson DB & Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 24(1):93-103.
2. Ishikawa H. et al., 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 461(7265):788-92.

Specifications

Activity: Control for ISD (CDS ligand)

Formulation: Naked or complexed with the transfection reagent LyoVec™

Sequence:

5’-TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA-3’

Quality control: 

• The inability to induce type I interferon (IFN) has been verified using cellular assays.
• The absence of bacterial contamination, such as lipoproteins and endotoxins, has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.

Contents

ISD Control Naked:

• 200 µg lyophilised ISD Control Naked
• 1.5 ml sterile endotoxin-free water

ISD Control/LyoVec™

• 100 µg lyophilised ISD Control/LyoVec™
  Note: Each vial contains 25 μg of ISD Control complexed with 50 μg LyoVec™.
• 10 ml sterile endotoxin-free water

Product is shipped at room temperature.

Upon receipt, store at -20°C.

Details

STING (stimulator of interferon genes) has become a focal point in immunology research and drug discovery [1, 2]. In a healthy individual, STING functions as a signaling hub, orchestrating immune responses to pathogenic, tumoral, or self-DNA detected in the cytoplasm [2]. Upon activation, STING induces type I interferon (IFN) production through TANK-binding-kinase-I (TBK1)-mediated IFN regulatory factor (IRF3) signaling [2]. STING activation also leads to NF‑κB-dependent inflammatory cytokine production [2]. In some autoimmune diseases such as STING-associated vasculopathy with onset in infancy (SAVI), STING is constitutively activated resulting in high IFN production [3, 4]. The discovery of a mechanism to pharmacologically inhibit STING should lead to new treatments for such diseases.

Reference:

1. Haag S.M. et al., 2018. Targeting STING with covalent small-molecule inhibitors. Nature 559:269-73.
2. Ishikawa H. & Barber G.N. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-8.
3. Liu Y. et al., 2014. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 371:507-18.
4. Jeremiah N. et al., 2013. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 124:5516-20.